Nadjet Rezki
Medina, 41411, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Design and synthesis of novel isatin-isoniazidhydrazone hybrid-based 1,2,3-triazoles as dual EGFR/PARP-1 inhibitors and apoptosis inducers in breast cancer cells.
Journal: Bioorganic chemistry
Published: February 01, 2026
Correction: Room temperature sensing of CO2 using C3-symmetry pyridinium-based porous ionic polymers with triazine or benzene cores.
Journal: RSC advances
Published: January 08, 2026
Triazole-Sulfonamide Hybrids as Carbonic Anhydrase Inhibitors: Emerging Chemistry and Bioactivity Insights From 2020 to 2025.
Journal: Archiv der Pharmazie
Published: September 30, 2025
Click synthesis of some novel benzo[d]thiazole-1,2,3-triazole hybrid compounds with benzamide and/or benzoate tethers as EGFR-dependent signaling inhibitors against breast cancer.
Journal: RSC medicinal chemistry
Published: July 26, 2025
Discovery of novel tris-1,2,3-triazole-based hybrids as VEGFR2 inhibitors with potent anti-proliferative and cytotoxicity through apoptosis induction.
Journal: Bioorganic chemistry
Published: November 13, 2024
Discovery of new benzothiazole-1,2,3-triazole hybrid-based hydrazone/thiosemicarbazone derivatives as potent EGFR inhibitors with cytotoxicity against cancer.
Journal: RSC advances
Published: October 21, 2024
Exploring of N-phthalimide-linked 1,2,3-triazole analogues with promising -anti-SARS-CoV-2 activity: synthesis, biological screening, and molecular modelling studies.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: June 07, 2024
Design and synthesis of chromene-1,2,3-triazole benzene sulfonamide hybrids as potent carbonic anhydrase-IX inhibitors against prostate cancer.
Journal: RSC medicinal chemistry
Published: April 27, 2024
Last Updated: 09/26/2026